“…Within the CareFirst market, the physician participation rate by practice type is 88% of communitybased oncologists, 44% of hospital-based oncologists, and 6% of academic-based oncologists, according to vice-president of pharmacy management, Winston Wong, PharmD. 1 In Michigan, 80% of the medical oncologists, representing community practices as well as three of the state's four largest academic centers, began using pathways in 2010, the first year of the program. P4's chief executive officer, Jeffrey Scott, MD, says that the combined total of oncologists using pathways in the Michigan program and the Carefirst program is approximately 500.…”